文献速递血管炎

IgA血管炎与抗GBM病:免疫复合物血管炎谱的两极

IgA vasculitis and anti-GBM disease: two ends of a spectrum of immune complex vasculitis.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

本文比较成人少见免疫复合物血管炎IgA血管炎(IgAV)与抗GBM病的当前诊疗策略。两者均有小血管坏死和肾小球新月体形成,但IgAV常保守治疗且长期肾脏结局研究不足,抗GBM病虽强化免疫抑制仍常致终末期肾衰竭;罕见IgA为主型抗GBM病临床过程同抗GBM病而非IgAV,提示抗原靶点而非抗体亚类决定结局。

要点

  • IgAV与抗GBM病均有小血管坏死和新月体形成,但诊疗与结局呈两极。
  • 抗GBM病强化免疫抑制后仍常进展至终末期肾衰竭。
  • IgA为主型抗GBM病临床过程同抗GBM病,提示抗原靶点决定结局。

核心结论

  • IgAV与抗GBM病虽同属免疫复合物血管炎且均有小血管坏死和新月体形成,但发病机制认知、标准化管理方案和结局呈两极。
  • 罕见IgA为主型抗GBM病临床过程同其他抗GBM病患者而非IgAV,提示决定疾病结局的关键因素是抗原靶点而非抗体亚类。

研究设计与样本

  • 本文为叙述性比较报告,比较成人IgAV与抗GBM病这两种少见免疫复合物血管炎的当前诊疗策略。

主要发现

  • IgAV的抗体应答针对未知抗原,常保守治疗,长期肾脏结局研究不足。
  • 抗GBM病表现为快速进展性肾小球肾炎,尽管强化免疫抑制仍常导致终末期肾衰竭。
  • 罕见抗GBM病病例可呈IgA为主型并结合GBM中其他α链,但临床过程同其他抗GBM病患者而非IgAV。
  • 两种疾病均与成人死亡率增加相关,并导致显著慢性肾脏病和高血压。

临床怎么用

  • 成人IgAV可保守治疗,但需关注长期肾脏结局及慢性肾脏病和高血压风险。
  • 抗GBM病需认识其快速进展性肾小球肾炎和常致终末期肾衰竭的预后。
  • 遇IgA为主型抗GBM病应按抗GBM病而非IgAV管理,因临床过程同抗GBM病。

局限性

  • 本文为叙述性比较报告,未报告系统检索范围或样本量等研究设计细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Two immune complex vasculitides, IgA vasculitis (IgAV) and anti-GBM disease, represent polar extremes with regard to our understanding of disease pathogenesis, standardized management protocols and outcomes. This report compares our current approach to these uncommon entities in adults. Both diseases demonstrate degrees of small vessel necrosis and glomerular crescent formation. IgAV has an antibody response directed against unknown antigens, is often treated conservatively and has poorly studied long term renal outcomes. By contrast, anti-GBM disease presents with rapidly progressive glomerulonephritis and often results in end stage renal failure, despite intensive immunosuppression. Rarely, some cases of anti-GBM disease may be IgA predominant and bind other α-chains present in the GBM, but their clinical course is as for other anti-GBM disease patients but not IgAV, suggesting that the antigenic target rather than the antibody subclass is the critical factor in determining disease outcome. However, both conditions are associated with increased mortality in adults and result in significant chronic kidney disease and hypertension.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Salama AD. IgA vasculitis and anti-GBM disease: two ends of a spectrum of immune complex vasculitis. Rheumatology (Oxford). 2020. PMID: 32348516. doi:10.1093/rheumatology/kez540

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。